(Q44511463)

English

Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

major depressive episode

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jean Dalery

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Adriaan Honig

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

379-384

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Fluoxetine and side effects

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

21 January 2018

Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative safety and tolerability of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

An interim overview of the safety and tolerability of paroxetine

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

The behavioural toxicity of the selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

The SSRIs: advantages, disadvantages and differences

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing SSRIs: From chemistry to clinical choice

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness

1 reference

https://api.crossref.org/works/10.1002%2FHUP.490

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.490

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44511463&oldid=2025997546"